This advisory defines attention deficit hyperactivity disorder in adults, and explains interactions with substance use disorders.

This quick guide helps clinicians and other service providers address suicide and suicide prevention in patients living with substance use disorders. It covers risk factors and warning signs for suicide, core competencies, and information for administrators and clinical supervisors.

This guide offers tips for program administrators on developing an effective program for clinical supervision in the substance use disorder treatment field. It addresses cultural competence, and describes supervisor ethics and values.

This advisory reviews diabetes and how it relates to mental illness, stress, and substance use disorders. It highlights ways to integrate diabetes care into behavioral health treatment, such as screening and intake, staff education, integrated care, and counseling support.

This guide offers tips for clinical supervisors in the substance use disorder treatment field. It covers functions of a clinical supervisor, and highlights stages of professional development for counselors and clinical supervisors.

This advisory gives an overview of extended-release injectable naltrexone for people with opioid dependence. It discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit.

This advisory equips substance use treatment and service providers with information about eating disorders and their relationship to substance use disorders. It provides an overview of screening, referrals, and evidence-based treatments for eating disorders and lists resources for more information.